Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal
Patent
1981-11-16
1983-08-30
Schain, Howard E.
Chemistry of carbon compounds
Miscellaneous organic carbon compounds
C-metal
260112R, 424 85, A61K 3944, C07G 700
Patent
active
044015925
ABSTRACT:
Disclosed is a novel pharmaceutical composition having antitumor (anti-cancer) activity without causing pyrexia and anaphylaxis, formed by an amide bonding between an antibody obtained by the purification of the antibody to tumor (cancer) antigen via affinity-chromatography and an antitumor substance (anti-cancer drug).
REFERENCES:
patent: 3917818 (1975-11-01), Botes
patent: 3947352 (1976-03-01), Cuatrecasas et al.
patent: 3983001 (1976-09-01), Coupek et al.
patent: 4017471 (1977-04-01), Davies
patent: 4046722 (1977-09-01), Rowland
patent: 4093607 (1978-06-01), Sela et al.
patent: 4123427 (1978-10-01), Daniel
patent: 4160018 (1979-07-01), Bjorklund
patent: 4195017 (1980-03-01), Bogoch
patent: 4223005 (1980-09-01), Teodoresev et al.
patent: 4228237 (1980-10-01), Hevey et al.
patent: 4263279 (1981-04-01), Sela et al.
patent: 4275000 (1981-06-01), Ross
patent: 4315851 (1982-02-01), Yoshikumi et al.
Nature, vol. 255, (1975), pp. 487, 488.
Microbiology Abstracts--Section B Bacteriology, vol. 8, No. 5, (1973), 8B4386 p. 164.
Febs Letters, vol. 28, No. 1, (1972), pp. 73-76.
J. Immunol. 113, pp. 948-953, Davphinee et al., (1974).
Cancer Research, 35, pp. 1182-1186 (1975), Levy et al.
Clin. Chem. 22/6, pp. 726-732 (1976), Broughton et al.
Science, vol. 169, 1970, pp. 68-70, Moolten et al.
Fujii Masahiko
Fujii Takayoshi
Matsunaga Ken-ichi
Niimura Koichi
Oguchi Yoshiharu
Kureha Kagaku Kogyo Kabushiki Kaisha
Schain Howard E.
LandOfFree
Pharmaceutical composition having antitumor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition having antitumor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition having antitumor activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-905195